SkinVive in Maidenhead

Clinical overview

SkinVive uses modified hyaluronic acid technology delivered as microdroplet injections into the skin. Unlike traditional dermal fillers that add volume or reshape facial contours, SkinVive is designed to improve overall skin quality — specifically skin smoothness, hydration and glow — from within the dermis. The treatment is primarily used in the cheek area, where microdroplets of hyaluronic acid are placed at a consistent depth across the treatment zone. This approach improves the skin's moisture retention and surface quality rather than providing structural support or lift. Results typically develop within the first week and can last several months. SkinVive is often suitable for patients who want a subtle, natural improvement in skin quality without visible volumising effects. It can complement other treatments such as dermal fillers, anti-wrinkle injections, or skin boosters like Profhilo, depending on your overall plan.

Key Benefits

• Improves skin smoothness and surface quality
• Enhances natural skin hydration and glow
• Does not add volume or change facial structure
• Quick treatment (approximately 15 minutes)
• Minimal downtime for most patients
• Results typically last several months

Suitable For

• Those seeking improved skin quality, smoothness and hydration
• Patients wanting a subtle, natural-looking enhancement rather than volume
• Adults with dull, dry or textured skin in the cheek area
• Those comfortable with injectable treatments and minimal downtime
• Patients looking to complement other aesthetic treatments as part of a broader plan

Not Suitable For

• Pregnant or breastfeeding women
• Those with known allergy or hypersensitivity to hyaluronic acid or lidocaine
• Patients with active skin infections, inflammation or open wounds in the treatment area
• Those with severe allergies or a history of anaphylaxis (requires careful assessment)
• Anyone expecting significant volume, lift or structural change from this treatment

Final suitability is confirmed during a medical consultation and assessment.

When we don't recommend it

• If your primary concern is volume loss, facial contouring or structural support — SkinVive does not add volume, and a different treatment plan is likely more appropriate.
• If you have active infection, inflammation or compromised skin in the treatment area — treatment should be delayed until the skin is healthy.
• If you have a known allergy to hyaluronic acid or lidocaine — alternative treatments should be considered.
• If expectations are for a dramatic or instant transformation — SkinVive provides subtle, quality-focused improvement rather than visible structural change.
• If a broader skin health plan (such as medical-grade skincare or other treatments) would better address your concerns as a first step.

What Happens During Treatment

1. 1Consultation to confirm suitability, review medical history and discuss realistic outcomes
2. 2Cleansing and preparation of the cheek area
3. 3Multiple microdroplet injections placed across the treatment zone
4. 4Treatment takes approximately 15 minutes
5. 5Aftercare guidance and follow-up plan discussed

Downtime & Aftercare

• Minimal downtime for most patients
• Small bumps at injection sites may appear initially and usually settle within 24–48 hours
• Mild swelling or redness for 24–48 hours is common
• Avoid touching or massaging the treated area for at least 6 hours
• Avoid heavy exercise, alcohol and excessive heat for 24 hours

Results Timeline

• Immediately after: small bumps and mild swelling at injection sites (settles within 24–48 hours).
• Days 3–7: improvements in skin smoothness and hydration typically become noticeable.
• Weeks 2–4: skin quality continues to improve as hydration effects develop.
• Months 3–6: maintenance treatment may be discussed to sustain results.

Individual results vary. View our results and photography standards

Risks & Side Effects

Common, Usually Temporary

• •Temporary bumps at injection sites (usually settle within 24–48 hours).
• •Mild swelling, redness or tenderness.
• •Bruising at injection sites (varies by individual).

Frequently Asked Questions